Firebrick Pharma Limited (FRE) is developing and commercialising novel formulations and uses of povidone iodine (PVP-I). The Company has developed and manufactured Nasodine Nasal Spray (0.5% PVP-I), which so far has been introduced into the United States, Singapore, and Fiji & South Pacific. The Company is pursuing approval in other markets, including the Philippines.
Find out what a historical investment in Firebrick Pharma Call 0.095 AUD Firebrick Pharma 04Jul28 Opt would be worth today using our FREO stock calculator.
Buying FREO shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Firebrick Pharma Call 0.095 AUD Firebrick Pharma 04Jul28 Opt in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in FREO
What is the ticker symbol of Firebrick Pharma Call 0.095 AUD Firebrick Pharma 04Jul28 Opt?
The ticker symbol for Firebrick Pharma Call 0.095 AUD Firebrick Pharma 04Jul28 Opt is FREO.
How much is one share of FREO?
One share of FREO is valued at $0.00 as of 20 November 2026.
What is the market capitalisation of Firebrick Pharma Call 0.095 AUD Firebrick Pharma 04Jul28 Opt FREO?
As of 20 November 2026 Firebrick Pharma Call 0.095 AUD Firebrick Pharma 04Jul28 Opt has a market cap of $9.24M.
What is the P/E ratio of FREO?
The Price to Earnings ratio of FREO is -0.25.
What is the Earnings Per Share of FREO?
The Earnings Per Share of FREO is -$0.01.
What is the 52-week high for Firebrick Pharma Call 0.095 AUD Firebrick Pharma 04Jul28 Opt stock?
The Firebrick Pharma Call 0.095 AUD Firebrick Pharma 04Jul28 Opt 52-week high stock price is $0.01.
What is the 52-week low for Firebrick Pharma Call 0.095 AUD Firebrick Pharma 04Jul28 Opt stock?
The Firebrick Pharma Call 0.095 AUD Firebrick Pharma 04Jul28 Opt 52-week low stock price is $0.00.
Can I buy FREO shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy FREO shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.